Optimizing Hemostasis in Hysteroscopic Myomectomy: A Randomized Clinical Trial of Vaginal Danazol Versus Diphereline in Women With Abnormal Uterine Bleeding
North American Proceedings in Gynecology and Obstetrics - Supplemental · 25.07.2026 · Suppl (MRSi)
DOI: 10.54053/001c.164969 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift North American Proceedings in Gynecology and Obstetrics - Supplemental, online erschienen am 25.07.2026. Verfasst von Sanam Bidadi und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To compare the efficacy of vaginal danazol versus Triptorelin in controlling intra-operative bleeding and improving surgical visualization during hysteroscopic myomectomy in women with abnormal uterine bleeding due to submucous myomas.
Design
Randomized controlled clinical trial. Materials and Methods: One hundred ninety reproductive-age women undergoing operative hysteroscopy were enrolled, and 30 were excluded. A total of 160 patients with submucous myomas were randomly assigned to receive either vaginal danazol (200 mg twice daily for 30 days preoperatively) or intramuscular triptorelin administered twice at a 28-day interval. Outcomes included severity of intra-operative bleeding, clarity of the surgical field, operative time, volume of distension media used, completion rate of surgery, and intra-operative complications. Statistical analysis compared categorical and continuous variables between groups, with significance set at p
Zitieren
APA
Bidadi, S., Melli, M. S., Taghavi, S., Ouladsahebmadarek, E., Jafari-Shobeiri, M., Ghojazadeh, M., & Rahmani, V. (2026). Optimizing Hemostasis in Hysteroscopic Myomectomy: A Randomized Clinical Trial of Vaginal Danazol Versus Diphereline in Women With Abnormal Uterine Bleeding. North American Proceedings in Gynecology and Obstetrics - Supplemental, Suppl(MRSi). https://doi.org/10.54053/001c.164969
Vancouver
Bidadi S, Melli MS, Taghavi S, Ouladsahebmadarek E, Jafari-Shobeiri M, Ghojazadeh M, et al. Optimizing Hemostasis in Hysteroscopic Myomectomy: A Randomized Clinical Trial of Vaginal Danazol Versus Diphereline in Women With Abnormal Uterine Bleeding. North American Proceedings in Gynecology and Obstetrics - Supplemental. 2026;Suppl(MRSi). doi:10.54053/001c.164969
BibTeX
@article{Bidadi2026,
author = {Bidadi, Sanam and Melli, Manijeh Sayyah and Taghavi, Simin and Ouladsahebmadarek, Elaheh and Jafari-Shobeiri, Mehri and Ghojazadeh, Morteza and Rahmani, Vahideh},
title = {Optimizing Hemostasis in Hysteroscopic Myomectomy: A Randomized Clinical Trial of Vaginal Danazol Versus Diphereline in Women With Abnormal Uterine Bleeding},
journal = {North American Proceedings in Gynecology and Obstetrics - Supplemental},
year = {2026},
volume = {Suppl},
number = {MRSi},
doi = {10.54053/001c.164969}
}
EUVIMED